Clinical Trial Update: Lapatinib and Cetuximab in Patients With Solid Tumors [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update reports completion of a study evaluating lapatinib and cetuximab in patients with solid tumors, including colorectal, lung, and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Head and Neck Cancer
• Lung Cancer

Drugs mentioned

• Cetuximab (Erbitux) (Cetuximab)
• Lapatinib (Tykerb) (lapatinib)

Snippet

Sponsor: Georgetown University | Conditions: Colorectal Cancer, Lung Cancer | Phase 1 | Status: COMPLETED